Risperidone in idiopathic and symptomatic dystonia: Preliminary experience

Neurological Sciences

Volumn 21, Issue 2, 2000, Pages 121-123

  Grassi, E ^a   Latorraca, S ^a   Piacentini, S ^a   Marini, P ^a   Sorbi, S ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Idiopathic dystonia; Movement disorders; Neuropsychiatric disorders; Pharmacological therapy; Risperidone; Symptomatic dystonia

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; IDIOPATHIC DISEASE; INVOLUNTARY MOVEMENT; MALE; TORSION DYSTONIA;

ADOLESCENT; ADULT; DOPAMINE ANTAGONISTS; DYSTONIA; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; RISPERIDONE; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 0033946164     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720070108     Document Type: Article

References (5)

1. Zuddas A, Cianchetti C (1996) Efficacy of risperidone in idiopathic segmental dystonia. Lancet 347:127-128
2. Leysen JE, Janssen MF, Megens HP, Schotte A (1994) Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 55[Suppl]:5-12
3. Burke RE, Fahn S, Marsden CD, Bressman SB et al (1985) Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35:73-77
4. Heykants J, Huang ML, Manners G et al (1995) The pharmacokinetics of risperidone in humans: a summary. J Clin Psychiatry 55[Suppl]:13-17
5. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP (1999) Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 47(6):716-719